Published in Gastroenterology on February 28, 2014
Gut/brain axis and the microbiota. J Clin Invest (2015) 1.64
Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci (2014) 1.47
N-3 Polyunsaturated Fatty Acids (PUFAs) Reverse the Impact of Early-Life Stress on the Gut Microbiota. PLoS One (2015) 1.46
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol (2015) 1.25
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol (2014) 1.19
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol (2015) 1.13
Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron (2015) 1.11
The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol (2014) 1.07
Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflamm Bowel Dis (2016) 1.02
Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol (2015) 0.97
Modulatory Effects of Gut Microbiota on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and Diseases. J Neurogastroenterol Motil (2016) 0.97
Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry (2015) 0.96
The human gut microbiota with reference to autism spectrum disorder: considering the whole as more than a sum of its parts. Microb Ecol Health Dis (2015) 0.87
Transmissible microbial and metabolomic remodeling by soluble dietary fiber improves metabolic homeostasis. Sci Rep (2015) 0.86
IBS-like symptoms in patients with ulcerative colitis. Clin Exp Gastroenterol (2015) 0.86
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85
Isolation of high-purity myenteric plexus from adult human and mouse gastrointestinal tract. Sci Rep (2015) 0.84
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol (2016) 0.81
Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome. J Gastroenterol (2015) 0.81
Gut Microbiota and Brain Function: An Evolving Field in Neuroscience. Int J Neuropsychopharmacol (2016) 0.80
The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol (2016) 0.80
The Role of Gut-brain Axis in Regulating Glucose Metabolism After Acute Pancreatitis. Clin Transl Gastroenterol (2017) 0.78
The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent. PLoS One (2015) 0.78
Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis. Gastroenterol Hepatol (N Y) (2015) 0.77
Cognitive Functions and Depression in Patients with Irritable Bowel Syndrome. Gastroenterol Res Pract (2015) 0.77
The microbiome of the oral mucosa in irritable bowel syndrome. Gut Microbes (2016) 0.76
Redirection of Epithelial Immune Responses by Short-Chain Fatty Acids through Inhibition of Histone Deacetylases. Front Immunol (2015) 0.76
Network analysis of temporal functionalities of the gut induced by perturbations in new-born piglets. BMC Genomics (2015) 0.75
Neurohormonal signalling in the gastrointestinal tract: new frontiers. J Physiol (2014) 0.75
Nopal feeding reduces adiposity, intestinal inflammation and shifts the cecal microbiota and metabolism in high-fat fed rats. PLoS One (2017) 0.75
Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders. Biomed Res Int (2016) 0.75
Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation. Adv Nutr (2017) 0.75
Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes (2016) 0.75
Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder. Cell Mol Gastroenterol Hepatol (2016) 0.75
Mechanism-Oriented Therapy of Irritable Bowel Syndrome. Adv Ther (2016) 0.75
Mechanistic understanding of the effects of probiotics in the modulation of abdominal pain: one study at a time. J Physiol (2015) 0.75
Human microbiome: From the bathroom to the bedside. World J Gastrointest Pathophysiol (2015) 0.75
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. Microbiome (2017) 0.75
Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World J Gastroenterol (2016) 0.75
Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. Digestion (2017) 0.75
The Maternal Gut Microbiome During Pregnancy. MCN Am J Matern Child Nurs (2017) 0.75
Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 17.30
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 15.22
The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87
The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (2013) 8.53
Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci (2001) 8.38
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2013) 8.37
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut (1987) 6.61
Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A (2011) 6.16
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci (2012) 4.95
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A (2011) 4.91
Chronic constipation. N Engl J Med (2003) 4.58
No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology (2013) 4.52
Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil (2009) 4.28
The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med (2011) 4.24
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol (2004) 3.52
Peripheral mechanisms in irritable bowel syndrome. N Engl J Med (2012) 3.40
Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol (2008) 3.15
Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci (2011) 3.15
Bacterial infection causes stress-induced memory dysfunction in mice. Gut (2010) 3.06
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol (2005) 2.99
Analyses of the microbial diversity across the human microbiome. PLoS One (2012) 2.98
Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology (2011) 2.79
Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) (2012) 2.72
Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun (2010) 2.69
Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract. Infect Immun (1974) 2.61
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
Irritable bowel syndrome in developing countries--a disorder of civilization or colonization? Neurogastroenterol Motil (2005) 2.60
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med (2005) 2.58
Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther (2012) 2.51
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut (2011) 2.49
Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil (2010) 2.47
Psychobiotics: a novel class of psychotropic. Biol Psychiatry (2013) 2.46
Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology (2013) 2.26
Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol (2009) 2.24
Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. Am J Gastroenterol (2013) 2.23
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med (2006) 2.16
Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther (2008) 2.13
Postinfectious irritable bowel syndrome. Gastroenterology (2003) 2.12
The neurobiology of stress and gastrointestinal disease. Gut (2000) 2.09
Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun (2010) 2.06
Prenatal stress alters bacterial colonization of the gut in infant monkeys. J Pediatr Gastroenterol Nutr (2004) 2.02
Antibiotics increase functional abdominal symptoms. Am J Gastroenterol (2002) 1.92
Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res (2006) 1.90
GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology (2013) 1.89
Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem (2005) 1.87
Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology (2010) 1.85
Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe (2012) 1.81
Epigenetic programming of stress responses through variations in maternal care. Ann N Y Acad Sci (2004) 1.81
Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol (2001) 1.79
Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol (2009) 1.76
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2012) 1.73
Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota. Proc Natl Acad Sci U S A (2013) 1.69
Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol (2005) 1.67
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut (2005) 1.63
An update on the use and investigation of probiotics in health and disease. Gut (2013) 1.62
Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. Rev Esp Enferm Dig (2013) 1.62
Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg (2000) 1.62
Stress stimulates transepithelial macromolecular uptake in rat jejunum. Am J Physiol (1998) 1.61
The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol (2011) 1.60
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol (2009) 1.60
Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev Psychobiol (1999) 1.57
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2011) 1.49
Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol (2007) 1.49
Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol (2008) 1.47
Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol (2004) 1.42
The fecal microbial population in the irritable bowel syndrome. Microbiologica (1982) 1.40
Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology (1998) 1.33
Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am J Physiol Gastrointest Liver Physiol (2002) 1.33
Microbial endocrinology and infectious disease in the 21st century. Trends Microbiol (2004) 1.32
The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil (2010) 1.32
Short chain fatty acids and their receptors: new metabolic targets. Transl Res (2012) 1.31
Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res (2011) 1.30
Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8. J Gastrointest Surg (2009) 1.28
Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A (2008) 1.28
SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One (2011) 1.28
Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut (2005) 1.27
Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr (2011) 1.23
Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation. Gastroenterology (2008) 1.22
Assessing gut microbial diversity from feces and rectal mucosa. Microb Ecol (2010) 1.21
Voices from within: gut microbes and the CNS. Cell Mol Life Sci (2012) 1.21
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 1.20
Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol (2009) 1.19
Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol (2012) 1.19
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog (2010) 1.17
Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther (2011) 1.15
Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol (2013) 1.15
Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr (1996) 1.14
Microbes and the gut-brain axis. Neurogastroenterol Motil (2012) 1.13
Norepinephrine increases the pathogenic potential of Campylobacter jejuni. Gut (2006) 1.13
Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil (2003) 1.11
The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterol Motil (2009) 1.08
Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol (2010) 1.08
Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol (2013) 1.07
Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand J Gastroenterol (2008) 1.07
Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol (2010) 1.02
Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol (1998) 1.01
Diet-microbiota interactions and their implications for healthy living. Nutrients (2013) 1.01